In many tumor systems, the location and extent of metastases are nonrandom, suggesting that unique cell properties are important in tumor arrest and formation of secondary tumor colonies. The lung and the liver are among the most frequently involved organs. These organs are also the predominant site of metastases by tumor cells of a model system of chemically induced lymphomas in DBA/2 mice that we have been investigating (1-5). The system consists of a low-metastatic parental tumor (Eb), a spontaneous high-metastatic variant thereof (ESb), and a high-metastatic tumor line of independent origin (MDAY-D2).
and then with 0.05% collagenase in the same buffer for 8-9 min. The liver was then removed, cut into pieces, filtered, and then suspended in Williams medium E supplemented with insulin and 15% FCS. Cells were washed three times for 15 min at 30g. 2 × 10 cells were plated into wells of Falcon multiwell tissue culture plates (No. 3008; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) in a total vol of 400/~1 supplemented Williams medium E. The cells were incubated at 37°C in 5% CO2 for 2-3 h and washed once before use.
Neuraminidase Treatment of Tumor Cells and Rosette Assay. Tumor cells were washed three times with Hanks' balanced salt solution. 20/xl of Neuraminidase test (1 U/ml from Vibrio comma [Vibrio cholerae] Behringwerke AG, Marburg/Lahn, Federal Republic of Germany), was added to 2 × 107 tumor cells in 1 ml and incubated at 37°C for 30 min. After three washes, the tumor cells were resuspended in 2 ml of Williams medium E. For the rosette assay, 250/~1 of ascites tumor-cell suspension (1 × 107/ml) was added to the hepatocyte culture and incubated at 37°C in 5% CO~ for 1 h. The cultured hepatoeytes were carefully washed three times before the number of rosette-forming cells was determined. Hepatocytes with three or more tumor cells bound were counted as rosette-forming cells (RFC).
Antibody-inhibition Test. Various alloantisera known to react with the tumor cells were used to test for possible blocking of rosette formation. 250/xl of tumor cells (107/ml) were preincubated with 25/~1 of appropriately diluted antisera at 37°C for 30 min. After two washes, they were then tested for their binding to the hepatocytes.
Results and Discussion
Freshly isolated hepatocytes from DBA/2 mice were incubated for 3 h in tissue culture medium in Petri dishes in order to attach to the dishes. They were then incubated for 1 h at 37°C with either of the three syngeneic tumor-cell lines, Eb, ESb, and MDAY-D2, and carefully washed. Examination of the cultures by an inverted microscope (Diavert; E. Leitz, Stuttgart, Federal Republic of Germany) revealed that the two metastatic tumor lines ESb and MDAY-D2 had attached to the liver cells whereas the low-metastatic parental tumor Eb had not ( Fig. 1 A and B) . About 40% of the hepatoeytes formed spontaneous rosettes with the metastatic tumor line ESb. The percentage of RFC and the average number of tumor cells bound per liver cell was greatly increased when the tumor cells were pretreated with neuraminidase ( Fig.  1 C and D) . Under these conditions, even the low-metastatic tumor Eb was bound by the hepatocytes (Fig. 1 C) . Freshly isolated liver cells without precuhure showed a decreased tendency to bind the tumor cells, so that no rosettes were observed with untreated tumor cells, and a smaller percentage bound neurarninidase-pretreated Eb or ESb tumor cells. This observation could be explained by adaptation of the liver cells to the tissue culture conditions, attachment to the plastic, and recovery from the collagenase pretreatment. That the tumor-cell binding was stable or even increased after recovery from enzyme treatment and was similarly observed after a prolonged culture period (24-72 h) indicates that the receptor responsible for the binding is not an artifact induced by the collagenase treatment but may be real and may play a physiological role in vivo.
The results from our syngeneic tumor model system suggest that hepatocytes bind metastasizing tumor cells better than nonmetastasizing ones. It remains to be investigated, however, with different tumor lines, whether this is a general phenomenon. Selectivity of the tumor-cell binding to hepatocytes was shown by the fact that other normal cells, such as Kupffer cells, peritoneal macrophages, lymphoid cells, and kidney cells (cell line BHK-21) did not form rosettes.
The dependency of tumor-hepatocyte-rosette formation on the temperature of incubation is illustrated in Fig. 2 . Virtually no rosettes were formed at 0°C and only a few at 4°C , a l t h o u g h at 2 2°C a b o u t as m a n y rosettes were f o r m e d w i t h the t u m o r c e l l s --w h e t h e r u n t r e a t e d or n e u r a m i n i d a s e p r e t r e a t e d --a s at 37°C. T h e s e results suggest that m e m b r a n e fluidity a n d possibly free m o v e m e n t o f receptors m a y be r e q u i r e d for the b i n d i n g of m e t a s t a t i c t u m o r cells by the hepatocytes. P r e t r e a t m e n t of the liver cells with cytochalasin B ( Table I . With the metastatic tumor line ESb, anti-H-2 sera produced quite strong inhibition, whereas the other two alloantibodies had either no effect (anti-non-H-2) or a comparatively weak inhibitory effect (antiThy-l.2). In contrast, when using the parental line Eb, which only bound to the liver cells after neuraminidase treatment, all three sera produced quite a good blocking effect. Compared to the cytotoxic titer assayed against the untreated tumor cells, antinon-H-2 serum was the strongest inhibitor of rosettes formed with Eb-N, whereas the anti-H-2 serum was the strongest inhibitor of rosettes formed with ESb or ESb-N.
Little is known about the mechanism of the tumor-cell-hepatocyte binding and its inhibition by specific antibody. Preliminary results indicate that the previously described lectin-like hepatic membrane receptor (7, 11) may mediate the spontaneous binding of the tumor cells. Exposure of hepatocytes to neuraminidase abolished their ability to specifically bind desialylated glycoproteins (12) , and also abolished their ability to bind the metastatic and the neuraminidase-treated Eb and ESb tumor cells (V. Schirrmacher, R. Cheingsong-Popov, and H. Arnheiter. Unpublished results.). The blocking by anti-H-2 serum was only observed when the tumor cells were pretreated, and not when the hepatocytes were pretreated with the antiserum. Allogeneic hepatocytes from C57BL/6 (H-2 b) formed rosettes equally well with ESb (H-2 d) as did the syngeneic hepatocytes from DBA/2 (H-2d), which suggests that alloantigenic compatibility is not required for the rosette formation. However, anti-H-2 d serum inhibited ESb rosettes with allogeneic as well as with syngeneic hepatocytes (V. Schirrmacher, R. Cheingsong-Popov, and H. Arnheiter. Unpublished Results.). These results may indicate that H-2 molecules play a role in the spontaneous interaction of the metastatic tumor cells with the hepatocytes. Binding of anti-H-2 antibody to the H-2 molecules possibly blocks by steric hindrance rather than by covering up the determinants recognized by the hepatocyte receptor, because alloantigenic determinants do not seem to be involved.
A number of other cell-interaction phenomena have been described to be under SCHIRRMACHER ET AL. BRIEF DEFINITIVE REPORT H-2 control: they include lymphocyte-lymphocyte and lymphocyte-macrophage interactions (13) and also nonimmunological reactions such as the adhesion of mouse fibroblasts (14) or the contact inhibition of kidney epithelial cells (15) . Further studies are aimed at a better characterization of the molecules involved in the interaction of normal hepatocytes with neoplastic cells. This may help to elucidate, at a molecular level, the liver tropism of many metastatic tumor cells and possibly to find selective competitive inhibitors for this process.
Summary
Murine hepatocytes, isolated by an in situ collagenase-perfusion technique and cultured in Petri dishes, were shown to form rosettes with liver-metastasizing syngeneic tumor cells. Pretreatment of the tumor cells with neuraminidase generally increased the binding, whereas pretreatment of the liver cells with neuraminidase abolished the binding completely. The tumor-cell binding may be mediated by the previously described lectin-like receptor of hepatocytes that also was sensitive to neuraminidase treatment and that bound desialylated cells better than normal cells.
Anti-H-2 sera could efficiently inhibit the rosette formation of metastatic tumor cells with the hepatocytes, which points to a possible role of H-2 molecules in this interaction of neoplastic and normal cells.
